A new survey has revealed that the funding status of moderate risk pension portfolios fell by more than six percent in February.
Pharmaceutical company Merck has just announced that it will merge with a major competitor Schering-Plough creating a multinational pharmaceutical giant.
In recent days, critical voices have spoken out against the FDA’s approach to the regulation of dietary supplements which they say overburdens their producers and benefits big pharma.
Scientists have found that both green and black tea may be useful in preventing serious cardiovascular events.
The American Heart Month may have ended last week, but a sports association’s healthy heart tips continue to inform and educate about beneficial lifestyle choices.
A Christian organization promoting traditional family values has criticized President Obama for plans to relax the enforcement of the amendments that protect healthcare providers’ right of conscience.
Alan Greenspan may be currently taking some heat as the man whose policies enabled financial institutions to lend irresponsibly, but he has faith in the U.S. market to recover within the next year – as long as banks receive the capital they need.
The FDA may have stated that melamine is safe in small doses, but food manufacturers seem to be playing it safe and recalling tainted products.
International economists are warning that unless the U.S. economy sees signs of a turnaround in the near future, the country could be headed for a deeper recession – or even a depression.
Two recent reports reveal that the rate of MRSA positivity among emergency room workers is more common than previously thought.
Senate Minority Leader Mitch McConnell has warned Congress not to rush plans for an early 2009 stimulus package, in order to avoid "wasting" taxpayers’ money.
In a climate where pharmaceutical drugs and traditional OTC medications can cause side effects and dangerous interactions, consumers are increasingly looking to alternative and natural products for relief of flu symptoms.
The Republican National Committee has blasted the Democratic administration’s $3.6 trillion budget proposal as too lavish and based on unrealistic economic expectations.
The Food and Drug Administration has issued its first approval for a medication that is produced using material from genetically engineered (GE) animals.
Scientists suspect that isoflavones may be able to reverse the androgenic effects of a steroid synthesized in the human body and play a role in prostate cancer prevention.
A recent Government Accountability Office report on the supplement market regulation has met with a mixed response from a leading industry association.
As civil rights advocates fight for the release of the Bush administration documents related to the war on terrorism, a group of government lawyers has revealed the CIA has destroyed videotapes of interrogation proceedings.
These days, it is all too easy to rely on potent drugs to reduce cholesterol levels, but one analysis has pointed out that pharmaceutical companies do not always have all the answers.
Scientists have demonstrated that antioxidants may shield animals from hearing loss due to noise exposure. Now they are trying to establish if this would also work in humans.
In response to a recent statement by Attorney General Eric Holder that the administration would consider banning semi-automatic rifles, an industry association has said a ban would be counterproductive and illegal.
The American Public Health Association (APHA) has set out to raise awareness of vitamin D deficiency among children and adults alike, a phenomenon that it sees as a top public health issue in the U.S.
A father of twins has filed a lawsuit against the Washington DC Water and Sewer Authority (WASA) accusing it of providing lead-tainted water that resulted in developmental problems in his children.
Like any piece of legislation the American Recovery and Reinvestment Act (ARRA) was always going to provoke mixed reactions, and medical advocacy groups are it finding it hard to agree on the implications of its privacy provisions.